570 Biowissenschaften; Biologie
Refine
Has Fulltext
- no (86)
Year of publication
Document Type
- Article (86) (remove)
Is part of the Bibliography
- yes (86)
Keywords
- FGF21 (3)
- acid sphingomyelinase (3)
- ceramide (3)
- inflammation (3)
- C. elegans (2)
- Insulin resistance (2)
- Mitochondria (2)
- Oxidative stress (2)
- Pregnancy (2)
- beta-cell (2)
- cancer (2)
- diabetes (2)
- fatty acid metabolism (2)
- genes (2)
- insulin (2)
- lipid metabolism (2)
- liver (2)
- mass spectrometry (2)
- mitochondria (2)
- proteasome (2)
- sphingolipids (2)
- 1-Methoxy-3-indolylmethyl glucosinolate (1)
- 1-aminodecylidene bis-phosphonic acid (1)
- 1-phosphate (1)
- 20S (1)
- 2D-LC-MS/MS (1)
- 7 macrophages (1)
- Adipocytes (1)
- Adipose tissue (1)
- Adult height (1)
- Advanced glycation endproducts (1)
- Aflatoxin B1 (1)
- African indigenous vegetables (1)
- Amaranth (1)
- Amaranthaceae (1)
- Arsenic-containing fatty acids (1)
- Arsenic-containing hydrocarbons (1)
- Arsenolipids (1)
- Aspergillus (1)
- Astrocytes (1)
- Autotaxin (1)
- B-phycoerythrin (1)
- BBsome (1)
- Bbs4 (1)
- Beryllium (1)
- Biomarker (1)
- Blood pressure (1)
- Blood protein adducts (1)
- Boron exposure (1)
- Brassica (1)
- Brassica rapa ssp. chinensis (1)
- C-reactive protein (1)
- CRISPR editing validation (1)
- Caco-2 intestinal barrier model (1)
- Caco-2/HT-29-MTX-model (1)
- Caenorhabditis elegans (1)
- Cancer prevention (1)
- Cardiovascular diseases (1)
- Carotenoid (1)
- Carotenoids (1)
- Cellular uptake (1)
- Cereals (1)
- Circadian rhythm (1)
- Complications in diabetes (1)
- Copper (1)
- DNA adducts (1)
- DNA damage (1)
- DNA damage response (1)
- DNMT inhibitor (1)
- Dendritic cells (1)
- Diabetes incidence (1)
- Drug delivery (1)
- EBI3 (1)
- Eicosanoid (1)
- Energy expenditure (1)
- Et-1 (1)
- Excretion (1)
- First trimester (1)
- Flavonoid (1)
- GCN2 (1)
- GDF15 (1)
- Glucosinolate breakdown product (1)
- Glycation (1)
- HPLC/HR-ESMS (1)
- HPLC/ICPMS (1)
- HRMS (1)
- Heat shock protein 90 (1)
- Heme (1)
- Hepatic insulin resistance (1)
- Hepatocytes (1)
- High resolution microscopy (1)
- Hormones (1)
- Hyperglycaemia (1)
- Hypertension (1)
- In vitro blood-brain barrier model (1)
- Insulin signaling (1)
- Intraperitoneal administration (1)
- Isoprostane (1)
- Jurkat cells (1)
- LC-MS/MS (1)
- LC–MS/MS (1)
- LEDs (1)
- LPA(3) receptor subtype (1)
- Labile zinc (1)
- Leg length (1)
- Light quality (1)
- Liver fat (1)
- Low birth weight (1)
- Lysophosphatidic acid (1)
- MALDI-TOF-MS (1)
- MMF (1)
- MSCs (1)
- Macrovascular (1)
- Marker (1)
- Mendelian randomization (1)
- Meta-analysis (1)
- MicroRNA (1)
- Microvascular complications (1)
- Modified mycotoxins (1)
- Multi-method (1)
- Mycotoxins (1)
- Myoglobin (1)
- NAD+ (1)
- NF-kappa B (1)
- NMR-based metabolomics (1)
- NZO (1)
- Nanoparticles (1)
- Neoglucobrassicin (1)
- Nutrition (1)
- OCFA (1)
- Obesity (1)
- Ontogeny (1)
- Oxylipin (1)
- Pak choi (1)
- Parkinson disease (1)
- Paternal exposure (1)
- Personalised medicine (1)
- Pesticides (1)
- PlGF (1)
- Precision medicine (1)
- Precision prognostics (1)
- Proteasome (1)
- Protein aggregates (1)
- Protein oxidation (1)
- Protein restriction (1)
- QTL (1)
- RAW 264 (1)
- RBP4 (1)
- RNAseq (1)
- ROS (1)
- Rats (1)
- Redox control (1)
- Retinol (1)
- Review (1)
- Risk (1)
- Risk prediction (1)
- S-XRF (1)
- SDS-PAGE (1)
- SIMS techniques (1)
- ST-1893 (1)
- ST-1894 (1)
- Se-methylselenoneine (1)
- Sex ratio at birth (1)
- Short stature (1)
- Skeletal muscle cells (1)
- Skin penetration (1)
- Small for gestational age (1)
- Smpd1 (1)
- Sphingolipids (1)
- TEM (1)
- TGF-beta (1)
- TNF alpha (1)
- TTR (1)
- Tenebrio molitor larvae (1)
- Testicle (1)
- Thermal processing (1)
- Toxicity (1)
- Trace elements (1)
- Trans-epoxy-fatty acid (1)
- Trunk length (1)
- Type 2 diabetes (1)
- Ulcerative colitis (1)
- Vitamin A (1)
- WAT (1)
- Warburg effect (1)
- World Cancer Research Fund/American Institute for Cancer Research Recommendations (1)
- Y:X chromosome ratio (1)
- Zinc (1)
- Zinc homeostasis (1)
- acid ceramidase (1)
- activated carbon (1)
- adiponectin (1)
- adipose tissue (1)
- adiposity (1)
- age (1)
- ageing (1)
- aging (1)
- alkylating agents (1)
- all-cause mortality (1)
- alternative splicing (1)
- amaranth (1)
- amino acids (1)
- and nutrition (1)
- anorexia (1)
- anthropometric measures (1)
- antioxidative capacity (1)
- anxiety-like behavior (1)
- apoptosis (1)
- appetite regulation (1)
- aroma quality (1)
- arsenolipids (1)
- asymmetric dimethylarginine (ADMA) (1)
- autophagy (1)
- base excision repair (incision activity) (1)
- beta-carotene hydroxylase (1)
- bioavailability (1)
- biofortification (1)
- biomarkers of renal failure (1)
- birth weight (1)
- bisphosphonates (1)
- blood banking (1)
- brain insulin signaling (1)
- browning (1)
- caffeic acid derivatives (1)
- calcination (1)
- cancer epidemiology (1)
- cardiokine (1)
- cardiovascular diseases (1)
- carotenoid biosynthesis (1)
- carotenoids (1)
- cellular bioimaging (1)
- cerami-des (1)
- ceramides (1)
- cereal meals (1)
- cholesterol (1)
- chronic diseases (1)
- cilium (1)
- circadian clock (1)
- clusterin (1)
- coffee by-products (1)
- colorectal neoplasm (1)
- colour (1)
- complications (1)
- constitutive androstane receptor (1)
- contrast-induced nephropathy (1)
- copper (1)
- copper-related disorders (1)
- copy number analyses (1)
- cortisol (1)
- cytokine (1)
- cytokines (1)
- database (1)
- decitabine (1)
- depressive-like behavior (1)
- design of experiment (1)
- diabetes mellitus (1)
- diet (1)
- diet quality (1)
- dietary patterns (1)
- dietary restriction (1)
- digestive enzymes quantification (1)
- disease (1)
- drug delivery (1)
- eating disorder symptoms (1)
- electrochemistry (1)
- enzyme induction (1)
- enzymology (1)
- epidemiology (1)
- epigenetic (1)
- exercise (1)
- experimental antigen-induced encephalomyelitis (1)
- failure (1)
- fatty acid profile (1)
- fatty pancreas (1)
- feeding (1)
- fermentation (1)
- fetal origins hypothesis (1)
- food (1)
- food frequency questionnaire (1)
- food group consumption (1)
- forebrain (1)
- fractionation (1)
- functional inhibitors of acid sphin-gomyelinase (1)
- functional properties (1)
- gallbladder cancer (1)
- glucocorticoid receptor (1)
- goblet cells (1)
- growth behavior (1)
- growth restriction (1)
- gwas (1)
- heart (1)
- homeostasis (1)
- homologous recombination deficiency (1)
- homology-directed repair (1)
- human excised skin (1)
- human liver microsomes (1)
- human milk (1)
- immune-inflammatory biomarkers (1)
- immunology (1)
- immunomodulator (1)
- in vitro intestinal model (1)
- infection (1)
- inhibitory cytokines (1)
- insect proteins (1)
- interleukin-35 (1)
- interleukin-8 (1)
- intestinal mucins (1)
- intestinal zinc resorption (1)
- ion-exchange chromatography (1)
- ionophore antibiotics (1)
- large population (1)
- later health (1)
- leucine (1)
- life cycle toxicities (1)
- lineage commitment (1)
- lipidomics (1)
- lipids (1)
- lipophagy (1)
- liver toxicity (1)
- loci (1)
- locus of control (1)
- long-chain polyunsaturated fatty acids (1)
- lung inflammation (1)
- lymphopenia (1)
- lysosomal hydrolases (1)
- lysosome (1)
- lysozyme (1)
- lysozyme activity (1)
- macrophages (1)
- maintenance of genomic integrity (1)
- manganese (1)
- mass index (1)
- mastery (1)
- meal timing (1)
- mealworm (1)
- melatonin (1)
- membrane fusion (1)
- methyl jasmonate (1)
- miRNAs (1)
- microcomputed tomography (1)
- micronutrients (1)
- microparticle (1)
- microwave-assisted extraction (1)
- mitochondria, (1)
- mixtures (1)
- molecular pathways (1)
- morpholino analogues of fingolimod (1)
- mucus layer (1)
- multiple sclerosis (1)
- muscle (1)
- muscle fibre composition (1)
- mustards (1)
- myokine (1)
- myopathy (1)
- nanogels (1)
- native American ancestry (1)
- neurodegenerative diseases (1)
- neurotoxicity (1)
- non-alcoholic fatty liver disease (1)
- nutrient transport (1)
- optimization (1)
- organic compounds adsorption (1)
- ovarian cancer (1)
- overweight (1)
- oxidative stress (1)
- parchment (1)
- patterns (1)
- phagocytosis (1)
- plasma (1)
- plasma measurements (1)
- platelets (1)
- poly(ADP-ribosyl)ation (1)
- polyphenols (1)
- population-specific risk marker (1)
- porphyridium purpureum (1)
- prediction (1)
- pregnancy (1)
- pregnane X-receptor (1)
- presystemic metabolism (1)
- proliferation (1)
- prostaglandin E2 (1)
- protein restriction (1)
- proteostasis (1)
- provitamin A (1)
- purification (1)
- rat (1)
- red wine (1)
- reliability (1)
- repeated measures design (1)
- repetitive elements (1)
- reproducibility (1)
- resistin (1)
- reversed-phase chromatography (1)
- risk (1)
- risk factors (1)
- sFlt-1 (1)
- salinomycin (1)
- saliva (1)
- salmon fish (1)
- sarcopenia (1)
- scores (1)
- selenoneine (1)
- serine palmitoyltransferase (1)
- sex (1)
- size (1)
- skin penetration (1)
- snacking (1)
- spent coffee grounds (1)
- sphingolipid de novo synthesis (1)
- sphingomyelin (1)
- sphingosine (1)
- sphingosine kinase-1 (1)
- stable-isotope labeling (1)
- storage (1)
- suPAR (1)
- tacrolimus formulation (1)
- targeted metabolomics (1)
- tea processing (1)
- tocopherols (1)
- total phenol content (1)
- transcriptomics (1)
- transformation product (1)
- transfusion-related acute lung injury (1)
- triazole fungicides (1)
- trypsin inhibitors (1)
- type 2 (1)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (1)
- validity (1)
- valine (1)
- valorization (1)
- variants (1)
- visfatin (1)
- volatile compounds (1)
- weight status (1)
- wheat (1)
- zinc (1)
- zinc binding (1)
- α-amylase (1)
- α-amylase/trypsin inhibitors (1)
Institute
- Institut für Ernährungswissenschaft (86) (remove)
Background: Dietary protein restriction is emerging as an alternative approach to treat obesity and glucose intolerance because it markedly increases plasma fibroblast growth factor 21 (FGF21) concentrations. Similarly, dietary restriction of methionine is known to mimic metabolic effects of energy and protein restriction with FGF21 as a required mechanism. However, dietary protein has been shown to be required for normal bone growth, though there is conflicting evidence as to the influence of dietary protein restriction on bone remodeling. The purpose of the current study was to evaluate the effect of dietary protein and methionine restriction on bone in lean and obese mice, and clarify whether FGF21 and general control nonderepressible 2 (GCN2) kinase, that are part of a novel endocrine pathway implicated in the detection of protein restriction, influence the effect of dietary protein restriction on bone.
Methods: Adult wild-type (WT) or Fgf21 KO mice were fed a normal protein (18 kcal%; CON) or low protein (4 kcal%; LP) diet for 2 or 27 weeks. In addition, adult WT or Gcn2 KO mice were fed a CON or LP diet for 27 weeks. Young New Zealand obese (NZO) mice were placed on high-fat diets that provided protein at control (16 kcal%; CON), low levels (4 kcal%) in a high-carbohydrate (LP/HC) or high-fat (LP/HF) regimen, or on high-fat diets (protein, 16 kcal%) that provided methionine at control (0.86%; CON-MR) or low levels (0.17%; MR) for up to 9 weeks. Long bones from the hind limbs of these mice were collected and evaluated with micro-computed tomography (mu CT) for changes in trabecular and cortical architecture and mass.
Results: In WT mice the 27-week LP diet significantly reduced cortical bone, and this effect was enhanced by deletion of Fgf21 but not Gcn2. This decrease in bone did not appear after 2 weeks on the LP diet. In addition, Fgf21 KO mice had significantly less bone than their WT counterparts. In obese NZO mice dietary protein and methionine restriction altered bone architecture. The changes were mediated by FGF21 due to methionine restriction in the presence of cystine, which did not increase plasma FGF21 levels and did not affect bone architecture.
Conclusions: This study provides direct evidence of a reduction in bone following long-term dietary protein restriction in a mouse model, effects that appear to be mediated by FGF21.
Epigenetic DNA methylation of EBI3 modulates human interleukin-35 formation via NFkB signaling
(2021)
Ulcerative colitis (UC), a severe chronic disease with unclear etiology that is associated with increased risk for colorectal cancer, is accompanied by dysregulation of cytokines. Epstein-Barr virus-induced gene 3 (EBI3) encodes a subunit in the unique heterodimeric IL-12 cytokine family of either pro- or anti-inflammatory function. After having recently demonstrated that upregulation of EBI3 by histone acetylation alleviates disease symptoms in a dextran sulfate sodium (DSS)-treated mouse model of chronic colitis, we now aimed to examine a possible further epigenetic regulation of EBI3 by DNA methylation under inflammatory conditions. Treatment with the DNA methyltransferase inhibitor (DNMTi) decitabine (DAC) and TNF alpha led to synergistic upregulation of EBI3 in human colon epithelial cells (HCEC). Use of different signaling pathway inhibitors indicated NF kappa B signaling was necessary and proportional to the synergistic EBI3 induction. MALDI-TOF/MS and HPLC-ESIMS/MS analysis of DAC/TNF alpha-treated HCEC identified IL-12p35 as the most probable binding partner to form a functional protein. EBI3/IL-12p35 heterodimers (IL-35) induce their own gene upregulation, something that was indeed observed in HCEC cultured with media from previously DAC/TNF alpha-treated HCEC. These results suggest that under inflammatory and demethylating conditions the upregulation of EBI3 results in the formation of anti-inflammatory IL-35, which might be considered as a therapeutic target in colitis.
Dysfunctional islets of Langerhans are a hallmark of type 2 diabetes (T2D). We hypothesize that differences in islet gene expression alternative splicing which can contribute to altered protein function also participate in islet dysfunction. RNA sequencing (RNAseq) data from islets of obese diabetes-resistant and diabetes-susceptible mice were analyzed for alternative splicing and its putative genetic and epigenetic modulators. We focused on the expression levels of chromatin modifiers and SNPs in regulatory sequences. We identified alternative splicing events in islets of diabetes-susceptible mice amongst others in genes linked to insulin secretion, endocytosis or ubiquitin-mediated proteolysis pathways. The expression pattern of 54 histones and chromatin modifiers, which may modulate splicing, were markedly downregulated in islets of diabetic animals. Furthermore, diabetes-susceptible mice carry SNPs in RNA-binding protein motifs and in splice sites potentially responsible for alternative splicing events. They also exhibit a larger exon skipping rate, e.g., in the diabetes gene Abcc8, which might affect protein function. Expression of the neuronal splicing factor Srrm4 which mediates inclusion of microexons in mRNA transcripts was markedly lower in islets of diabetes-prone compared to diabetes-resistant mice, correlating with a preferential skipping of SRRM4 target exons. The repression of Srrm4 expression is presumably mediated via a higher expression of miR-326-3p and miR-3547-3p in islets of diabetic mice. Thus, our study suggests that an altered splicing pattern in islets of diabetes-susceptible mice may contribute to an elevated T2D risk.
Macrophages in pathologically expanded dysfunctional white adipose tissue are exposed to a mix of potential modulators of inflammatory response, including fatty acids released from insulin-resistant adipocytes, increased levels of insulin produced to compensate insulin resistance, and prostaglandin E₂ (PGE₂) released from activated macrophages. The current study addressed the question of how palmitate might interact with insulin or PGE₂ to induce the formation of the chemotactic pro-inflammatory cytokine interleukin-8 (IL-8). Human THP-1 cells were differentiated into macrophages. In these macrophages, palmitate induced IL-8 formation. Insulin enhanced the induction of IL-8 formation by palmitate as well as the palmitate-dependent stimulation of PGE₂ synthesis. PGE₂ in turn elicited IL-8 formation on its own and enhanced the induction of IL-8 release by palmitate, most likely by activating the EP4 receptor. Since IL-8 causes insulin resistance and fosters inflammation, the increase in palmitate-induced IL-8 formation that is caused by hyperinsulinemia and locally produced PGE₂ in chronically inflamed adipose tissue might favor disease progression in a vicious feed-forward cycle.
Arsenic-containing hydrocarbons (AsHCs), a subgroup of arsenolipids (AsLs) occurring in fish and edible algae, possess a substantial neurotoxic potential in fully differentiated human brain cells. Previous in vivo studies indicating that AsHCs cross the blood–brain barrier of the fruit fly Drosophila melanogaster raised the question whether AsLs could also cross the vertebrate blood–brain barrier (BBB). In the present study, we investigated the impact of several representatives of AsLs (AsHC 332, AsHC 360, AsHC 444, and two arsenic-containing fatty acids, AsFA 362 and AsFA 388) as well as of their metabolites (thio/oxo-dimethylpropionic acid, dimethylarsinic acid) on porcine brain capillary endothelial cells (PBCECs, in vitro model for the blood–brain barrier). AsHCs exerted the strongest cytotoxic effects of all investigated arsenicals as they were up to fivefold more potent than the toxic reference species arsenite (iAsIII). In our in vitro BBB-model, we observed a slight transfer of AsHC 332 across the BBB after 6 h at concentrations that do not affect the barrier integrity. Furthermore, incubation with AsHCs for 72 h led to a disruption of the barrier at sub-cytotoxic concentrations. The subsequent immunocytochemical staining of three tight junction proteins revealed a significant impact on the cell membrane. Because AsHCs enhance the permeability of the in vitro blood–brain barrier, a similar behavior in an in vivo system cannot be excluded. Consequently, AsHCs might facilitate the transfer of accompanying foodborne toxicants into the brain.
Amaranth is presently an underutilized crop despite its high content of micronutrients/bioactive phytochemicals and its capacity to thrive in harsh environmental condition. The present study aimed at determining the health benefits of Amaranthus cruentus L. in terms of protection against DNA damage induced by the mycotoxin aflatoxin B1 (AFB1) and oxidative stress using comet assay. The antioxidant potential was further investigated using electron paramagnetic resonance spectroscopy (EPR) and an ARE/Nrf2 reporter gene assay in vitro in a human liver model using the HepG2 cell line. Ethanolic extracts from fresh leaves grown under controlled conditions were used and additionally analyzed for their phytochemical content using liquid chromatography-mass spectrometry (LC-MS). The extracts inhibited both AFB1- and oxidative stress-induced DNA damage in a concentration dependent way with a maximum effect of 57% and 81%, respectively. Oxidative stress triggered using ferrous sulfate was blocked by up to 38% (EPR); the potential to induce antioxidant enzymes using ARE/Nrf2-mediated gene expression was also confirmed. Based on these in vitro findings, further studies on the health-protecting effects of A. cruentus are encouraged to fully explore its health promoting potential and provide the scientific basis for encouraging its cultivation and consumption.
The objective of this work was to investigate the potential effect of cereal α-amylase/trypsin inhibitors (ATIs) on growth parameters and selective digestive enzymes of Tenebrio molitor L. larvae. The approach consisted of feeding the larvae with wheat, sorghum and rice meals containing different levels and composition of α-amylase/trypsin inhibitors. The developmental and biochemical characteristics of the larvae were assessed over feeding periods of 5 h, 5 days and 10 days, and the relative abundance of α-amylase and selected proteases in larvae were determined using liquid chromatography tandem mass spectrometry. Overall, weight gains ranged from 21% to 42% after five days of feeding. The larval death rate significantly increased in all groups after 10 days of feeding (p < 0.05), whereas the pupation rate was about 25% among larvae fed with rice (Oryza sativa L.) and Siyazan/Esperya wheat meals, and only 8% and 14% among those fed with Damougari and S35 sorghum meals. As determined using the Lowry method, the protein contents of the sodium phosphate extracts ranged from 7.80 ± 0.09 to 9.42 ± 0.19 mg/mL and those of the ammonium bicarbonate/urea reached 19.78 ± 0.16 to 37.47 ± 1.38 mg/mL. The total protein contents of the larvae according to the Kjeldahl method ranged from 44.0 and 49.9 g/100 g. The relative abundance of α-amylase, CLIP domain-containing serine protease, modular serine protease zymogen and C1 family cathepsin significantly decreased in the larvae, whereas dipeptidylpeptidase I and chymotrypsin increased within the first hours after feeding (p < 0.05). Trypsin content was found to be constant independently of time or feed material. Finally, based on the results we obtained, it was difficult to substantively draw conclusions on the likely effects of meal ATI composition on larval developmental characteristics, but their effects on the digestive enzyme expression remain relevant.
The aim of this study was to determine the effect of blanching followed by fermentation of mealworms (Tenebrio molitor) with commercial meat starter cultures on the functional properties of powders produced from the larvae. Full fat and defatted powder samples were prepared from non-fermented and fermented mealworm pastes. Then the crude protein, crude fat, and dry matter contents, pH, bulk density, colour, water and oil binding capacity, foaming capacity and stability, emulsion capacity and stability, protein solubility, quantity of free amino groups, and protein composition of the powders were evaluated. Regardless of the starter culture used, the blanching plus fermentation process reduced the crude and soluble protein contents of the full fat powders and in general impaired their water and oil binding, foaming, and emulsifying properties. Defatting of the powders improved most functional properties studied. The o-phthaldialdehyde assay revealed that the amount of free amino groups was higher in the fermented powders while sodium dodecyl sulfate polyacrylamide gel electrophoresis demonstrated that the soluble proteins of the fermented powders were composed of molecules of lower molecular mass compared to non-fermented powders. As molecular sizes of the soluble proteins decreased, it was clear that the protein structure was also modified by the fermentation process, which in turn led to changes in functional properties. In general, it was concluded that fermentation of mealworms with blanching as a pre-treatment does not contribute to the functional properties studied in this work. Nevertheless, the results confirmed that the properties of non-fermented powders are comparable to other food protein sources.
Pancreatic steatosis associates with beta-cell failure and may participate in the development of type-2-diabetes. Our previous studies have shown that diabetes-susceptible mice accumulate more adipocytes in the pancreas than diabetes-resistant mice. In addition, we have demonstrated that the co-culture of pancreatic islets and adipocytes affect insulin secretion. The aim of this current study was to elucidate if and to what extent pancreas-resident mesenchymal stromal cells (MSCs) with adipogenic progenitor potential differ from the corresponding stromal-type cells of the inguinal white adipose tissue (iWAT). miRNA (miRNome) and mRNA expression (transcriptome) analyses of MSCs isolated by flow cytometry of both tissues revealed 121 differentially expressed miRNAs and 1227 differentially expressed genes (DEGs). Target prediction analysis estimated 510 DEGs to be regulated by 58 differentially expressed miRNAs. Pathway analyses of DEGs and miRNA target genes showed unique transcriptional and miRNA signatures in pancreas (pMSCs) and iWAT MSCs (iwatMSCs), for instance fibrogenic and adipogenic differentiation, respectively. Accordingly, iwatMSCs revealed a higher adipogenic lineage commitment, whereas pMSCs showed an elevated fibrogenesis. As a low degree of adipogenesis was also observed in pMSCs of diabetes-susceptible mice, we conclude that the development of pancreatic steatosis has to be induced by other factors not related to cell-autonomous transcriptomic changes and miRNA-based signals.
Aims/hypothesis Low-protein diets are well known to improve glucose tolerance and increase energy expenditure. Increases in circulating fibroblast growth factor 21 (FGF21) have been implicated as a potential underlying mechanism. Methods We aimed to test whether low-protein diets in the context of a high-carbohydrate or high-fat regimen would also protect against type 2 diabetes in New Zealand Obese (NZO) mice used as a model of polygenetic obesity and type 2 diabetes. Mice were placed on high-fat diets that provided protein at control (16 kJ%; CON) or low (4 kJ%; low-protein/high-carbohydrate [LP/HC] or low-protein/high-fat [LP/HF]) levels. Results Protein restriction prevented the onset of hyperglycaemia and beta cell loss despite increased food intake and fat mass. The effect was seen only under conditions of a lower carbohydrate/fat ratio (LP/HF). When the carbohydrate/fat ratio was high (LP/HC), mice developed type 2 diabetes despite the robustly elevated hepatic FGF21 secretion and increased energy expenditure. Conclusion/interpretation Prevention of type 2 diabetes through protein restriction, without lowering food intake and body fat mass, is compromised by high dietary carbohydrates. Increased FGF21 levels and elevated energy expenditure do not protect against hyperglycaemia and type 2 diabetes per se.